subscribeSubscribe
Hetero`s Generic Eluxadoline Receives Approval in the U.S.

Hetero`s Generic Eluxadoline Receives Approval in the U.S.
FDA
10 Aug 2023
Share Share
Sun Pharma`s Generic Eluxadoline Receives Approval in the US

Sun Pharma`s Generic Eluxadoline Receives Approval in the US
FDA
17 Nov 2021
Share Share
Zydus Cadila receives tentative approval from US FDA for Eluxadoline tablets

Zydus Cadila receives tentative approval from US FDA for Eluxadoline tablets
EXPRESS PHARMA
15 Nov 2021
Share Share
FDA Confirms Paragraph IV Patent Challenge of Viberzi 206940 (Eluxadoline) Tablets 75 mg and 100 mg

FDA Confirms Paragraph IV Patent Challenge of Viberzi 206940 (Eluxadoline) Tablets 75 mg and 100 mg

FDA
01 Aug 2019
Share Share
Allergan Reports New Data Reinforcing the Effectiveness of Viberzi® Eluxadoline

Allergan Reports New Data Reinforcing the Effectiveness of Viberzi® Eluxadoline
PR NEWSWIRE
10 Jul 2017
Share Share
FDA Warns of Increased Risk of Serious Pancreatitis with Allergan’s Viberzi

FDA Warns of Increased Risk of Serious Pancreatitis with Allergan’s Viberzi
Zachary Brennan RAPS
16 Mar 2017
Share Share
Allergan CEO: 2017 should be Kybella`s breakout year

Allergan CEO: 2017 should be Kybella`s breakout year
Carly Helfand FIERCE PHARMA
12 Jan 2017
Share Share
Fitch Affirms Allergan at `BBB-`; Outlook Stable

Fitch Affirms Allergan at `BBB-`; Outlook Stable
REUTERS
08 Dec 2016
Share Share
Valeant looks to revive Xifaxan with primary care sales effort. Will it work?

Valeant looks to revive Xifaxan with primary care sales effort. Will it work?
Carly Helfand FIERCE PHARMA
02 Dec 2016
Share Share
Allergan teams with star paratriathlete in yet another effort to boost Viberzi

Allergan teams with star paratriathlete in yet another effort to boost Viberzi
Carly Helfand FIERCE PHARMA
23 Nov 2016
Share Share